• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy.

作者信息

Hainaut Pierre, Plymoth Amelie

出版信息

Curr Opin Oncol. 2013 Jan;25(1):50-1. doi: 10.1097/CCO.0b013e32835b651e.

DOI:10.1097/CCO.0b013e32835b651e
PMID:23150341
Abstract
摘要

相似文献

1
Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy.靶向癌症的特征：迈向新一代癌症治疗的合理方法。
Curr Opin Oncol. 2013 Jan;25(1):50-1. doi: 10.1097/CCO.0b013e32835b651e.
2
Simulating the hallmarks of cancer.模拟癌症的特征。
Artif Life. 2006 Fall;12(4):617-34. doi: 10.1162/artl.2006.12.4.617.
3
Hallmarks of cancer: the next generation.癌症的特征：下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
4
Protein growth factors and cytokines are typically thought to drive the proliferative/invasive/survival hallmarks of cancer. Preface.
Cancer Metastasis Rev. 2011 Dec;30(3-4):275-6. doi: 10.1007/s10555-011-9323-y.
5
Tumor cell metabolism: cancer's Achilles' heel.肿瘤细胞代谢：癌症的致命弱点。
Cancer Cell. 2008 Jun;13(6):472-82. doi: 10.1016/j.ccr.2008.05.005.
6
Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.逃避肿瘤的逃避：抗血管生成癌症治疗的当前概念和观点。
Drug Resist Updat. 2010 Feb-Apr;13(1-2):16-28. doi: 10.1016/j.drup.2009.12.001. Epub 2010 Jan 12.
7
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.癌症相关炎症——癌症的第七个标志：与基因不稳定性的联系
Carcinogenesis. 2009 Jul;30(7):1073-81. doi: 10.1093/carcin/bgp127. Epub 2009 May 25.
8
Scatter factors and invasive growth.散射因子与侵袭性生长
Semin Cancer Biol. 2001 Apr;11(2):153-65. doi: 10.1006/scbi.2000.0366.
9
Cancer: a de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer.癌症：所有细胞普遍存在的默认生存程序的去抑制？从生命史的角度看癌症的本质。
Bioessays. 2012 Jan;34(1):72-82. doi: 10.1002/bies.201100049. Epub 2011 Nov 22.
10
[Molecular targeting as a new strategy for cancer chemotherapy].[分子靶向治疗作为癌症化疗的新策略]
Fukuoka Igaku Zasshi. 2000 Jan;91(1):1-7.

引用本文的文献

1
Development and validation of a nomogram for predicting immunotherapy outcomes in lung cancer patients using clinical and blood biomarkers.使用临床和血液生物标志物预测肺癌患者免疫治疗结果的列线图的开发与验证
BMC Cancer. 2025 Aug 22;25(1):1353. doi: 10.1186/s12885-025-14559-1.
2
Exploring Multiplex Immunohistochemistry (mIHC) Techniques and Histopathology Image Analysis: Current Practice and Potential for Clinical Incorporation.探索多重免疫组织化学（mIHC）技术与组织病理学图像分析：当前实践与临床应用潜力
Cancer Med. 2025 Jan;14(1):e70523. doi: 10.1002/cam4.70523.
3
The Distribution and Predictive Factor of Extra-Pancreatic Malignancy Occurrence in Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm-A Ten-Year Follow-Up Case-Control Study in Taiwan.
胰腺导管内乳头状黏液性肿瘤患者胰外恶性肿瘤发生的分布及预测因素——台湾一项十年随访病例对照研究
Cancers (Basel). 2024 Dec 7;16(23):4102. doi: 10.3390/cancers16234102.
4
Exploring the protective effect of silver nano-extract against azoxymethane induced toxicity in female reproductive organs in rats.探索纳米银提取物对大鼠雌性生殖器官中由氧化偶氮甲烷诱导的毒性的保护作用。
Heliyon. 2024 Oct 5;10(21):e38820. doi: 10.1016/j.heliyon.2024.e38820. eCollection 2024 Nov 15.
5
Assessment of the efficacy and safety of anlotinib for the treatment of recurrent epithelial ovarian cancer.评价安罗替尼治疗复发性上皮性卵巢癌的疗效和安全性。
Discov Oncol. 2024 Aug 29;15(1):383. doi: 10.1007/s12672-024-01267-8.
6
Comprehensive Analysis of Kisspeptin Signaling: Effects on Cellular Dynamics in Cervical Cancer.Kisspeptin 信号的综合分析：对宫颈癌中细胞动力学的影响。
Biomolecules. 2024 Jul 29;14(8):923. doi: 10.3390/biom14080923.
7
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as an Early Prognostic Marker in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为卵巢癌患者早期预后标志物的系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Jun 1;25(6):1921-1927. doi: 10.31557/APJCP.2024.25.6.1921.
8
Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.肿瘤细胞以还原型的形式表达和维持高迁移率族蛋白 B1（HMGB1），以增强 CXCR4 介导的迁移。
Front Immunol. 2024 May 13;15:1358800. doi: 10.3389/fimmu.2024.1358800. eCollection 2024.
9
Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors.通过两种pH敏感脂质膜穿透肽（pHLIP）将二聚体STINGa靶向细胞内递送用于实体瘤治疗。
Front Pharmacol. 2024 Mar 1;15:1346756. doi: 10.3389/fphar.2024.1346756. eCollection 2024.
10
[A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].[TTC9A表达水平及其与预后和免疫微环境的相关性的泛癌分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jan 20;44(1):70-82. doi: 10.12122/j.issn.1673-4254.2024.01.09.